Two of Opus's seven gene therapy assets are in clinical trials, with additional programs expected to enter the clinic.
Ocugen has announced the publication of positive results from its phase 1 GARDian1 trial of OCU410ST, a gene therapy for ...
It’s medicine through music, therapy through theatre, even healing through the Harlem shake. And Canada is becoming a leader ...
The US Food and Drug Administration has granted breakthrough therapy designation to Oculis’ neuroprotective candidate ...
Yes, therapy can improve a lawyer’s performance by helping regulate their nervous system, reducing stress, and building ...
Privosegtor is advancing in the registrational PIONEER program across 2 key optic neuropathies, representing an unaddressed potential market of $7 billion in the U.S. Privosegtor achieved an average ...
Children with amblyopia who used the AmblyoPlay app 5 days a week for 6 months had significant improvements in visual acuity, ...
The FDA granted breakthrough therapy designation to privosegtor, a novel peptoid small molecule for the treatment of optic ...
Time Walker on MSN
This walkway in Shenzhen China is a visual treat
Discover a peaceful walking experience in the heart of Shenzhen, China. This urban pathway is surrounded by neatly trimmed ...
Atsena Therapeutics, a clinical-stage gene therapy company focused on using the life-changing power of genetic medicine to reverse or prevent blindness, today announced that dosing is complete in ...
ZHUHAI, GUANGDONG, CHINA, January 13, 2026 /EINPresswire.com/ -- What drives global fitness industry leaders to ...
RALEIGH, NC - January 06, 2026 - PRESSADVANTAGE - Active Chiropractic has added a Styku scanner to its range of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback